Financhill
Back

Edgewise Therapeutics Stock Predictions

Edgewise Therapeutics Stock Forecast

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 11.1% based on the past 4 years of stock performance.
  • Edgewise Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Edgewise Therapeutics Stock Undervalued?
    The current Edgewise Therapeutics [EWTX] share price is $15.26. The Score for EWTX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • EWTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Edgewise Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Edgewise Therapeutics has on average historically risen by 11.1% based on the past 4 years of stock performance.

Edgewise Therapeutics Stock Rating

Sell
43
Edgewise Therapeutics (EWTX) is a Sell

Is Edgewise Therapeutics overpriced?

  • Edgewise Therapeutics has risen higher in 2 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Edgewise Therapeutics Stock Price History

Is EWTX stock going to rise?

  • The current trend is relatively stagnant and EWTX is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
edgewisetx.com

52-Week Data

52-Week High:
38.12
52-Week Low:
10.60

Prediction Charts

Market Cap:
1.6B
Price in USD:
15.26
Volume:
974.8K
Beta:
0.29

Technical Analysis

SMA50:
14.74
SMA100:
20.57
SMA200:
24.28
52-Wk Change:
-13.59%

Stock Predictions

  • Is Edgewise Therapeutics stock public?
    Yes, Edgewise Therapeutics is a publicly traded company.
  • What is the Edgewise Therapeutics stock quote today?
    The Edgewise Therapeutics stock price is 15.26 USD today.
  • How to buy Edgewise Therapeutics stock online?
    You can buy Edgewise Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-20 14.80 14.87 15.34 14.68
May-21 14.70 14.59 14.84 14.13
May-22 14.54 14.02 14.60 13.98
May-23 14.05 14.21 14.31 13.63
May-27 14.49 14.33 14.68 13.89
May-28 14.38 13.99 14.65 13.95
May-29 14.15 14.57 14.60 13.80
May-30 14.56 14.28 14.70 13.84
Jun-2 14.38 14.69 14.71 13.94
Jun-3 14.73 14.84 15.05 14.39
Jun-4 14.91 14.49 15.00 14.43
Jun-5 14.47 14.82 14.90 14.16
Jun-6 15.11 15.24 15.60 14.97
Jun-9 15.57 15.26 15.69 14.86

Edgewise Therapeutics Earnings

Edgewise Therapeutics Earnings Report: Per Share Edgewise Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Edgewise Therapeutics Forecast Revenue Growth

Edgewise Therapeutics Stock Analysis: Historical quarterly revenues per share for Edgewise Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.26 per share, and a decrease next year of $0.22 per share.

* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.